261 related articles for article (PubMed ID: 37860676)
1. Molecular genetic aberrations in the pathogenesis of multiple myeloma.
Bong IPN; Esa E
Asian Biomed (Res Rev News); 2023 Aug; 17(4):152-162. PubMed ID: 37860676
[TBL] [Abstract][Full Text] [Related]
2. Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.
Heider M; Nickel K; Högner M; Bassermann F
Oncol Res Treat; 2021; 44(12):672-681. PubMed ID: 34749378
[TBL] [Abstract][Full Text] [Related]
3. Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.
Salomon-Perzyński A; Jamroziak K; Głodkowska-Mrówka E
Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573876
[TBL] [Abstract][Full Text] [Related]
4. Genomic Aberrations in Multiple Myeloma.
Manier S; Salem K; Glavey SV; Roccaro AM; Ghobrial IM
Cancer Treat Res; 2016; 169():23-34. PubMed ID: 27696256
[TBL] [Abstract][Full Text] [Related]
5. Utilizing next-generation sequencing in the management of multiple myeloma.
Lionetti M; Neri A
Expert Rev Mol Diagn; 2017 Jul; 17(7):653-663. PubMed ID: 28524737
[TBL] [Abstract][Full Text] [Related]
6. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
7. Plasma cell myeloma: role of histopathology, immunophenotyping, and genetic testing.
Fitzpatrick MJ; Nardi V; Sohani AR
Skeletal Radiol; 2022 Jan; 51(1):17-30. PubMed ID: 33687521
[TBL] [Abstract][Full Text] [Related]
8. Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.
Ndacayisaba LJ; Rappard KE; Shishido SN; Ruiz Velasco C; Matsumoto N; Navarez R; Tang G; Lin P; Setayesh SM; Naghdloo A; Hsu CJ; Maney C; Symer D; Bethel K; Kelly K; Merchant A; Orlowski R; Hicks J; Mason J; Manasanch EE; Kuhn P
Curr Oncol; 2022 Apr; 29(5):2954-2972. PubMed ID: 35621632
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of multiple myeloma: New insights and modern technologies.
Hultcrantz M; Yellapantula V; Rustad EH
Best Pract Res Clin Haematol; 2020 Mar; 33(1):101153. PubMed ID: 32139018
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Clinical Characteristics and Genetic Aberrations of Plasma Cell Disorders in Thailand Population.
Jirabanditsakul C; Dakeng S; Kunacheewa C; U-Pratya Y; Owattanapanich W
Technol Cancer Res Treat; 2022; 21():15330338221111228. PubMed ID: 35770320
[TBL] [Abstract][Full Text] [Related]
11. [Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].
Kosztolányi S; Horváth B; Hosnyánszki D; Kereskai L; Sziládi E; Jáksó P; Alizadeh H; Szuhai K; Alpár D; Kajtár B
Orv Hetil; 2019 Jun; 160(24):944-951. PubMed ID: 31433233
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
Sawyer JR
Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
[TBL] [Abstract][Full Text] [Related]
13. Genomic heterogeneity in multiple myeloma.
Szalat R; Munshi NC
Curr Opin Genet Dev; 2015 Feb; 30():56-65. PubMed ID: 25982873
[TBL] [Abstract][Full Text] [Related]
14. Circulating MicroRNAs in Multiple Myeloma: a Literature Review.
Tiruneh T; Melku M
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337835
[TBL] [Abstract][Full Text] [Related]
15. Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/Relapse.
Mlynarcikova M; Balcarkova J; Mickova P; Scudla V; Pika T; Bacovsky J; Minarik J; Janousova E; Jarosova M
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):358-65. PubMed ID: 27052024
[TBL] [Abstract][Full Text] [Related]
16. Genomic instability in multiple myeloma: mechanisms and therapeutic implications.
Neri P; Bahlis NJ
Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S69-82. PubMed ID: 23782016
[TBL] [Abstract][Full Text] [Related]
17. Using MMRFBiolinks R-Package for Discovering Prognostic Markers in Multiple Myeloma.
Settino M; Cannataro M
Methods Mol Biol; 2022; 2401():289-314. PubMed ID: 34902136
[TBL] [Abstract][Full Text] [Related]
18. Clonal Evolution in Multiple Myeloma.
Fakhri B; Vij R
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S130-4. PubMed ID: 27521309
[TBL] [Abstract][Full Text] [Related]
19. [The pathology and genetic background of myeloma].
Timár B
Magy Onkol; 2016 Jun; 60(2):145-53. PubMed ID: 27275641
[TBL] [Abstract][Full Text] [Related]
20. Genomic complexity of multiple myeloma and its clinical implications.
Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
